117093 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Metalloendopeptidases (3.4.24) Lysostaphin (3.4.24.75)
BACTERIOLYSIS METHOD, BACTERIOLYSIS AID, AND METHOD FOR DETERMINING THE PRESENCE OR ABSENCE OF BACTERIA
#2CORYNEBACTERIUM TO TREAT OR LIMIT CUTANEOUS WOUND INFECTION
#3UNGLYCOSYLATED LYSOSTAPHIN VARIANT PROTEIN
#4RECOMBINANT POLYPEPTIDE FOR USE AS A MEDICINE, ANTISEPTIC AGENT, ANTIBACTERIAL AGENT, ANTI-INFLAMMATORY AGENT, COMPOSITIONS COMPRISING IT AND USES THEREOF
#5LYSOSTAPHIN VARIANTS AND METHODS OF USE THEREOF
#6BACTERIOLYSIS METHOD AND BACTERIA DETECTION METHOD
#7Genetically Modified Mycoplasma Bacteria Active Against Heterogenous Bacterial Biofilms
#8Methods for Lysis of Cells Within a Sample
#9CHIMERIC PROTEINS FOR SELECTIVE LYSIS OF BACTERIA
#10VIRAL MEDIATED GENE DELIVERY FOR TRANSIENT EXPRESSION OF PROTEINS
#11Unglycosylated lysostaphin variant protein
#12COMPOSITIONS AND METHODS FOR NON-ANTIBIOTIC TREATING OF BACTERIAL INFECTIONS BY BLOCKING OR DISRUPTING BACTERIAL GENES INVOLVED IN VIRULENCE OR VIABILITY
#13BLOOD COMPONENT POTENTIATION OF LYTIC PROTEIN ANTI-BACTERIAL ACTIVITY AND METHODS AND USES THEREOF
#14Deimmunized lysostaphin and methods of use
#15Methods for Lysis of Cells Within a Sample
#16Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
#17Compositions and methods for non-antibiotic treating of bacterial infections by blocking or disrupting bacterial genes involved in virulence or viability
#18Deimmunized lysostaphin and methods of use
#19Chimeric polypeptides and their use in bacterial decolonization
#20Antimicrobial agents against
#21Vasoconstrictive and antibacterial combination treatment for rosacea
#22Method for detecting contained in milk
#23Method for detecting contained in milk
#24Chimeric polypeptides and their use in bacterial decolonization
#25Multimodal antimicrobial therapy
#26Deimmunized lysostaphin and methods of use
#27Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
#28Method for detecting contained in milk
#29Unglycosylated lysostaphin variant protein
#30Antimicrobial Enzyme Fusions Reduce Resistance and Kill Intracellular Staphylococcus aureus
#31ANTIMICROBIAL COMPOSITIONS
#32Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5
#33Chimeric polypeptides and their use in bacterial decolonization
#34Multimodal antimicrobial therapy
#35Ultra-Low Dose Lysostaphin for Treating MRSA
#36Method of peptide hydrolysis, peptidase, the composition for use as a bacteriostatic and bactericidal agent, a kit and the uses of the active form of LytM from or derivatives thereof
#37Antimicrobial Coating for Surgical Implants and Method of Manufacturing
#38Enhanced staphylolytic activity of the bacteriophage vBSauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5
#39Chimeric polypeptides and their use in bacterial decolonization
#40Antimicrobial Coating for Surgical Implants and Method of Use
#41Lys K endolysin is synergistic with lysostaphin against MRSA
#42Method of Treatment of Inflammatory Diseases
#43Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase
#44Compositions Comprising Lysostaphin Variants And Methods Of Using The Same
#45Antimicrobial polymer conjugates
#46Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains